Page 210 - Hall et al (2015) Principles of Critical Care-McGraw-Hill
P. 210

2      References


                   28. Hopkins RO, Weaver LK, Collingridge D, Parkinson RB, Chan     45. van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin
                      KJ, Orme JF Jr. Two-year cognitive, emotional, and quality-  therapy in the medical ICU. N Engl J Med. 2006;354(5):449-461.
                      of-life outcomes in acute respiratory distress syndrome. Am J     46. Stevens RD, Dowdy DW, Michaels RK, Mendez-Tellez PA,
                      Respir Crit Care Med. 2005;171(4):340-347.             Pronovost PJ, Needham DM. Neuromuscular dysfunction
                   29. Dowdy DW, Eid MP, Sedrakyan A, et al. Quality of life in adult   acquired in critical illness: a systematic review. Intensive Care
                      survivors of critical illness: a systematic review of the literature.   Med. 2007;33(11):1876-1891.
                      Intensive Care Med. 2005;31(5):611-620.             47. Vanhorebeek I, De VR, Mesotten D, Wouters PJ, De Wolf-Peeters C,
                   30. Rothenhausler HB, Ehrentraut S, Stoll C, Schelling G,   van den Berghe G.  Protection of hepatocyte mitochondrial
                      Kapfhammer HP. The relationship between cognitive perfor-  ultrastructure and function by strict blood glucose control with
                      mance and employment and health status in long-term survi-  insulin in critically ill patients. Lancet. 2005;365(9453):53-59.
                      vors of the acute respiratory distress syndrome: results of an     48. Deem S, Lee CM, Curtis JR. Acquired neuromuscular dis-
                      exploratory study. Gen Hosp Psychiatry. 2001;23(2):90-96.  orders in the intensive care unit. Am J Respir Crit Care Med.
                   31. Kapfhammer  HP, Rothenhausler  HB,  Krauseneck  T,  Stoll  C,   2003;168(7):735-739.
                      Schelling G. Posttraumatic stress disorder and health-related     49. Siroen MP, van Leeuwen PA, Nijveldt RJ, Teerlink T, Wouters
                      quality of life in long-term survivors of acute respiratory distress   PJ, van den BG. Modulation of asymmetric dimethylarginine
                      syndrome. Am J Psychiatry. 2004;161(1):45-52.          in critically ill patients receiving intensive insulin treatment: a
                   32. Cox  CE,  Docherty SL,  Brandon  DH,  et  al.  Surviving  critical   possible explanation of reduced morbidity and mortality? Crit
                      illness: acute respiratory distress syndrome as experienced   Care Med. 2005;33(3):504-510.
                      by patients and their caregivers.  Crit Care Med. 2009;37(10):     50. Aljada A, Ghanim H, Mohanty P, Kapur N, Dandona P. Insulin
                      2702-2708.                                             inhibits the pro-inflammatory transcription factor early growth
                   33. Levine S, Nguyen T, Taylor N, et al. Rapid disuse atrophy of   response gene-1 (Egr)-1 expression in mononuclear cells
                      diaphragm fibers in mechanically ventilated humans. N Engl J   (MNC) and reduces plasma tissue factor (TF) and plasminogen
                      Med. 2008;358(13):1327-1335.                           activator inhibitor-1 (PAI-1) concentrations. J Clin Endocrinol
                   34. De Jonghe B, Sharshar T, Lefaucheur JP, et al. Paresis acquired in   Metab. 2002;87(3):1419-1422.
                      the intensive care unit: a prospective multicenter study. JAMA.     51. Ishii DN, Lupien SB. Insulin-like growth factors protect against
                      2002;288(22):2859-2867.                                diabetic neuropathy: effects on sensory nerve regeneration in
                   35. Griffiths RD, Hall JB. Intensive care unit-acquired weakness.   rats. J Neurosci Res. 1995;40(1):138-144.
                      Crit Care Med. 2010;38(3):779-787.                  52. Garnacho-Montero J, Madrazo-Osuna J, Garcia-Garmendia JL,
                   36. Latronico N, Bolton CF. Critical illness polyneuropathy and   et al. Critical illness polyneuropathy: risk factors and clinical
                      myopathy: a major cause of muscle weakness and paralysis.   consequences. A cohort study in septic patients. Intensive Care
                      Lancet Neurol. 2011;10(10):931-941.                    Med. 2001;27(8):1288-1296.
                   37. Bolton CF,  Gilbert  JJ, Hahn AF,  Sibbald WJ.  Polyneuropathy     53. Leatherman  JW, Fluegel  WL,  David  WS,  Davies  SF,  Iber  C.
                      in critically ill patients.  J Neurol Neurosurg Psychiatry.   Muscle weakness in mechanically ventilated patients with severe
                      1984;47(11):1223-1231.                                 asthma. Am J Respir Crit Care Med. 1996;153(5):1686-1690.
                   38. de Letter MA, Schmitz PI, Visser LH, et al. Risk factors for the     54. Behbehani NA, Al-Mane F, D’yachkova Y, Pare P, FitzGerald
                      development of polyneuropathy and myopathy in critically ill   JM. Myopathy following mechanical ventilation for acute severe
                      patients. Crit Care Med. 2001;29(12):2281-2286.        asthma: the role of muscle relaxants and corticosteroids . Chest.
                                                                             1999;115(6):1627-1631.
                   39. Stevens RD, Dowdy DW, Michaels RK, Mendez-Tellez PA,
                      Pronovost PJ, Needham DM. Neuromuscular dysfunction     55. MacFarlane IA, Rosenthal FD. Severe myopathy after status
                      acquired in critical illness: a systematic review. Intensive Care   asthmaticus. Lancet. 1977;2(8038):615.
                      Med. 2007;33(11):1876-1891.                         56. Stevens RD, Dowdy DW, Michaels RK, Mendez-Tellez PA,
                   40. van den BG, Schoonheydt K, Becx P, Bruyninckx F, Wouters PJ.   Pronovost PJ, Needham DM. Neuromuscular dysfunction
                      Insulin therapy protects the central and peripheral nervous sys-  acquired in critical illness: a systematic review. Intensive Care
                      tem of intensive care patients. Neurology. 2005;64(8):1348-1353.  Med. 2007;33(11):1876-1891.
                   41. Stevens RD, Dowdy DW, Michaels RK, Mendez-Tellez PA,     57. Thiele RI, Jakob H, Hund E, et al. Sepsis and catecholamine
                      Pronovost PJ, Needham DM. Neuromuscular dysfunction    support are the major risk factors for critical illness polyneu-
                      acquired in critical illness: a systematic review. Intensive Care   ropathy after open heart surgery.  Thorac  Cardiovasc  Surg.
                      Med. 2007;33(11):1876-1891.                            2000;48(3):145-150.
                   42. Fenzi F, Latronico N, Refatti N, Rizzuto N. Enhanced expression     58. Pandit L, Agrawal A. Neuromuscular disorders in critical ill-
                      of E-selectin on the vascular endothelium of peripheral nerve   ness. Clin Neurol Neurosurg. 2006;108(7):621-627.
                      in critically ill patients with neuromuscular disorders.  Acta     59. Papazian L, Forel JM, Gacouin A, et al. Neuromuscular block-
                      Neuropathol (Berl). 2003;106(1):75-82.                 ers in early acute respiratory distress syndrome. N Engl J Med.
                   43. Hotchkiss RS, Swanson PE, Freeman BD, et al. Apoptotic cell   2010;363(12):1107-1116.
                      death in patients with sepsis, shock, and multiple organ dys-    60. Latronico N, Fenzi F, Recupero D, et al. Critical illness myopa-
                      function. Crit Care Med. 1999;27(7):1230-1251.         thy and neuropathy. Lancet. 1996;347(9015):1579-1582.
                   44. van den Berghe G, Wouters P, Weekers F, et al. Intensive     61. Campellone JV, Lacomis D, Kramer DJ, Van Cott AC, Giuliani
                      insulin therapy in the critically ill patients.  N  Engl  J  Med.   MJ. Acute myopathy after liver transplantation.  Neurology.
                      2001;345(19):1359-1367.                                1998;50(1):46-53.









            Section01-O-ref.indd   2                                                                                   12/10/2014   8:06:43 PM
   205   206   207   208   209   210   211   212   213   214   215